The implications of HB 6667 are significant for the federal regulatory landscape. By limiting the ability of federal agencies to engage in consent decrees, the bill could alter how regulations are developed and enforced, potentially shifting the balance of regulatory powers. Supporters argue that it will prevent judicial actions from leading to regulations that could unjustly burden businesses and limit the scope of federal oversight. The goal is to ensure that any regulations enforceable by agencies must undergo proper legislative processes rather than originating from court settlements.
Summary
House Bill 6667, known as the 'No Regulation Through Litigation Act of 2023', aims to restrict the capacity of federal agencies to enter into consent decrees and settlement agreements that could impose regulations. Specifically, the bill prohibits federal agencies from engaging in settlements or consent decrees that exceed the authority of the courts involved in such agreements. Additionally, it seeks to eliminate the inclusion of attorneys' fees and litigation costs in federal agency settlement agreements that lead to new regulations or guidance documents. This legislation is positioned as a measure to curb what its sponsors define as overreach through litigation.
Contention
Notable points of contention surrounding HB 6667 include concerns raised by various stakeholders, including environmental and consumer protection advocates. Critics assert that the bill may limit agency effectiveness in enforcing regulations aimed at protecting public health, safety, and the environment. They argue that consent decrees often serve as vital tools for achieving compliance and ensuring accountability from entities that may otherwise evade regulatory scrutiny. The possibility that this legislation might curtail the necessary oversight raises questions about its potential to foster a less regulated environment, which could negatively affect public welfare.